Yu Wentao, Sui Wu, Mu Linsong, Yi Wenying, Li Haijuan, Wei Liqin, Yin Weihong
Department of General Surgery and Pediatric Surgery, The Affiliated Yantai Yuhuangding Hospital of Qingdao University Medical College Department of Ultrasound, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong, China.
Medicine (Baltimore). 2017 May;96(21):e6652. doi: 10.1097/MD.0000000000006652.
Necrotizing enterocolitis (NEC) is a serious multifactorial gastrointestinal disease which is often discovered in premature infants. Various additives have been used to prevent NEC; yet, their relative efficacy and safety remain disputed. This study aims to compare the efficacy and safety of 5 food additives, namely, probiotics, probiotics + fructo-oligosaccharides, pentoxifylline, arginine, and lactoferrin in preventing NEC in neonates.
Embase, PubMed, and Cochrane Library had been searched for all eligible randomized control trials. Odds ratios (ORs) were estimated for dichotomous data and mean differences with 95% credible intervals (CrIs) were estimated for continuous data. Surface under the cumulative ranking curve was used to rank efficacy and safety of the prevention methods on each endpoint.
A total of 27 eligible studies with 4649 preterm infants were included in this network meta-analysis (NMA), and the efficacy and safety of 5 food additives were evaluated. Probiotic and arginine exhibited better preventive efficacy compared with placebo (OR = 0.50, 95% CrIs: 0.32-0.73; OR = 0.30, 95% CrIs: 0.12-0.73, respectively). Only probiotic achieved a considerable decrease in the risk of mortality compared to placebo (OR = 0.68, 95% CrIs: 0.46-0.98). NEC patients with lactoferrin appeared to have lower incidence of sepsis than those of placebo (OR = 0.13, 95% CrIs: 0.03-0.61) or probiotic (OR = 0.18, 95% CrIs: 0.03-0.83).
Based on this NMA, probiotics had the potential to be the most preferable additive, since it exhibited a significant superiority for NEC and mortality as well as a relatively balanced performance in safety.
坏死性小肠结肠炎(NEC)是一种严重的多因素胃肠道疾病,常见于早产儿。多种添加剂已被用于预防NEC;然而,它们的相对疗效和安全性仍存在争议。本研究旨在比较5种食品添加剂,即益生菌、益生菌+低聚果糖、己酮可可碱、精氨酸和乳铁蛋白在预防新生儿NEC方面的疗效和安全性。
检索了Embase、PubMed和Cochrane图书馆中所有符合条件的随机对照试验。对于二分数据,估计比值比(OR);对于连续数据,估计均值差异及95%可信区间(CrI)。累积排序曲线下面积用于对各终点预防方法的疗效和安全性进行排序。
本网络荟萃分析(NMA)共纳入27项符合条件的研究,涉及4649名早产儿,评估了5种食品添加剂的疗效和安全性。与安慰剂相比,益生菌和精氨酸表现出更好的预防效果(OR分别为0.50,95%CrI:0.32-0.73;OR为0.30,95%CrI:0.12-0.73)。与安慰剂相比,只有益生菌能显著降低死亡风险(OR为0.68,95%CrI:0.46-0.98)。使用乳铁蛋白的NEC患者败血症发生率似乎低于安慰剂组(OR为0.13,95%CrI:0.03-0.61)或益生菌组(OR为0.18,95%CrI:0.03-0.83)。
基于本NMA,益生菌有可能成为最优选的添加剂,因为它在预防NEC和降低死亡率方面表现出显著优势,且安全性表现相对平衡。